GAD65 Antibodies, Chronic Psychosis, and Type 2 Diabetes Mellitus

| August 31, 2011 | 0 Comments

by Atmaram Yarlagadda, MD; Jerome H. Taylor, Jr., MD; Christiane S. Hampe, PhD; Elizabeth Alfson, MD; and Anita H. Clayton, MD
Dr. Yarlagadda is Assistant Professor, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, Virginia; Dr. Taylor is from the Yale Child Study Center, New Haven, Connecticut; Dr. Hampe is Research Associate Professor, Department of Medicine, University of Washington, Seattle, Washington; Dr. Alfson is from the Brigham and Women’s Hospital, Boston, Massachusetts; and Dr. Clayton is Professor, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia.

Innov Clin Neurosci. 2011;8(8):34–36

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , , , ,

Category: Medical Issues, Psychiatry, Schizophrenia, Update on Blood Brain Barrier

Leave a Reply